Evaluation of Pharmacogenetic Factors Affecting Fentanyl Requirements for Postoperative Pain Control
NCT ID: NCT00824772
Last Updated: 2013-06-04
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
204 participants
OBSERVATIONAL
2008-09-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association Between Clinical Effect of Morphine With PCA After Surgery and Pharmacogenetics
NCT01233752
Association Between Clinical Effect of Continuous Morphine Administration After Surgery and Pharmacogenetics
NCT01233219
Pharmacokinetic, Pharmacodynamic and Pharmacogenetic of Morphine After Surgery
NCT00822549
Impact of CYP3A4*1G Polymorphism on Metabolism of Fentanyl in Chinese Patients Undergoing Lower Abdominal Surgery
NCT01181492
Pharmacogenetic-guided Choice of Post-surgery Analgesics
NCT05548660
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who want to use intravenous patient controlled analgesia (PCA) after surgery
* ASA physical status class I, II
Exclusion Criteria
* opioid medication within 12 hours before surgery
* previous history of opioid medication for 3 months
* neurologic disorder
* cardiac disorder
* hepatic disease
* renal disease
* respiratory disease such as COPD, asthma
* sleep apnea
* BMI \> 30
* psycotic disorder
19 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inje University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kye-Min Kim
Associate professor, Department of Anesthesiolgy & Pain Medicine, Inje University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kye-Min Kim, MD. PhD.
Role: PRINCIPAL_INVESTIGATOR
Department of Anesthesia, Inje University Sanggye Paik Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Inje University Sanggye Paik Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kim KM, Kim HS, Lim SH, Cheong SH, Choi EJ, Kang H, Choi HR, Jeon JW, Yon JH, Oh M, Shin JG. Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Korean gynecologic patients. Int J Clin Pharmacol Ther. 2013 May;51(5):383-92. doi: 10.5414/CP201824.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00012007317-00
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.